Efficacy of Dexmedetomidine in Preventing Contrast Induced Nephropathy
NCT02137863
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Radiographic Contrast Agent Nephropathy
Interventions
DRUG:
Dexmedetomidine
DRUG:
0.9 % NaCl
DRUG:
0.9 % NaCl
Sponsor
TC Erciyes University